Lin X, Thiemann N R, Pease L R, Rodriguez M
Department of Immunology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Virology. 1995 Dec 1;214(1):91-9. doi: 10.1006/viro.1995.9951.
Resistance to Theiler's virus-induced demyelination maps genetically to the MHC class I D region and is associated with up-regulation of class I products and the presence of MHC-restricted virus-specific cytotoxic CD8+ T cells in the CNS. To determine the targets of the cytotoxic response, transfected C57SV (Kb, Db) cells expressing LP (including the leader peptide, VP4, VP2, and VP3 coding sequences), VP4 (including the leader peptide and VP4), VP2, VP3, VP1, or RP (including P2 and P3) were generated. CNS-infiltrating lymphocytes obtained from virus-infected B10, B10.K (Kk, Dk), B10.RBF (Kb, Df). B10.RFB3 (Kf, Db), and B10.RBQ (Kb, Dq) mice were used as effectors. Specific cytotoxicity to the capsid proteins encoded in the LP construct, VP2 and VP1, was demonstrated to be H-2Db region restricted and was mediated by CD8+ T cells. No Kb-restricted virus-specific cytotoxicity response was observed. No specific cytotoxic response against RP-encoded proteins was observed in the CNS of B10 mice. Therefore, both VP1 and VP2 are targets for an H-2D-restricted cytotoxic immune response against Theiler's virus infection in the CNS of infected resistant B10 mice.
对泰勒氏病毒诱导的脱髓鞘的抗性在基因上定位于MHC I类D区域,并且与I类产物的上调以及中枢神经系统中MHC限制性病毒特异性细胞毒性CD8 + T细胞的存在相关。为了确定细胞毒性反应的靶标,构建了表达LP(包括前导肽、VP4、VP2和VP3编码序列)、VP4(包括前导肽和VP4)、VP2、VP3、VP1或RP(包括P2和P3)的转染C57SV(Kb,Db)细胞。从病毒感染的B10、B10.K(Kk,Dk)、B10.RBF(Kb,Df)、B10.RFB3(Kf,Db)和B10.RBQ(Kb,Dq)小鼠中获得的中枢神经系统浸润淋巴细胞用作效应细胞。对LP构建体中编码的衣壳蛋白VP2和VP1的特异性细胞毒性被证明是H-2Db区域限制性的,并且由CD8 + T细胞介导。未观察到Kb限制性病毒特异性细胞毒性反应。在B10小鼠的中枢神经系统中未观察到针对RP编码蛋白的特异性细胞毒性反应。因此,VP1和VP2都是感染抗性B10小鼠中枢神经系统中针对泰勒氏病毒感染的H-2D限制性细胞毒性免疫反应的靶标。